Background illustration for clinical trials search

Paid Clinical Trials Killeen

Discover 680 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Austin TX, Tyler TX, Columbia MO, Aurora CO,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Austin TX, Arlington TX, San Antonio TX, Houston TX,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Austin TX, West Columbia SC, Fort Lauderdale FL,
Sponsor: Ocular Therapeutix, Inc.

Sex: All

Age: 50+

Code: NCT07516132

Phase3, Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Austin TX, Schertz TX, Willow Park TX, Fort Worth TX,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

for
Geographic Atrophy (GA)
Location: Austin TX, Dallas TX, The Woodlands TX, Lakewood CO,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50+

Code: NCT07230834

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Neoadjuvant Darovasertib in Primary Uveal Melanoma

for
Uveal Melanoma
Location: Austin TX, Dallas TX, Nashville TN, Aurora CO,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07015190

Phase3, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Austin TX, Dallas TX, Houston TX, St Louis MO,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Austin TX, Dallas TX, San Antonio TX, Houston TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

Quality of Pediatric Resuscitation in a Multicenter Collaborative

for
Cardiac Arrest, Cardiopulmonary Arrest
Location: Austin TX, San Antonio TX, Dallas TX, St Louis MO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT02708134

Recruiting

Virtual Reality Distraction During Pediatric Intravenous Line Placement

for
Pediatric IV Placement, Virtual Reality Distraction
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 4 - 17

Code: NCT03304769

Recruiting

Advanced SPinal Innovations With Robotics and Enabling Technology Registry

for
Spine Deformity, Idiopathic Scoliosis,
Location: Austin TX, Aurora CO, Atlanta GA, Charleston SC,
Sponsor: Boston Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT05071144

Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Austin TX, Dallas TX, Oklahoma City OK, Little Rock AR,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase2, Phase3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Austin TX, Fort Worth TX, Dallas TX, San Antonio TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

for
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma,
Location: Austin TX, Dallas TX, Houston TX, Memphis TN,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 18

Code: NCT05504291

Phase2, Recruiting

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

for
Niemann-Pick Diseases, Acid Sphingomyelinase Deficiency
Location: Austin TX, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Sanofi

Sex: All

Age: 0 - 2

Code: NCT06192576

Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Austin TX, Dallas TX, Little Rock AR, Kansas City MO,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Austin TX, Fort Worth TX, Dallas TX, San Antonio TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Austin TX, Dallas TX, Saint Louis MI, Aurora CO,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Austin TX, Houston TX, Little Rock AR,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Austin TX, Dallas TX, San Antonio TX, Corpus Christi TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting